Journal of Animal Breeding and Genomics (J Anim Breed Genom)
1 February 2017 Enacted
1 September 2026 Revised
JABG adheres to the guidelines and best practices published by professional organizations, including ICMJE Recommendations and the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice). Furthermore, all processes of handling research and publication misconduct (or when faced with cases of suspected misconduct) shall follow the applicable Committee on Publication Ethics (COPE) flowcharts (https://publicationethics.org/guidance). Any attempts to duplicate publications or engage in plagiarism will lead to immediate rejection, may prejudice the acceptance of future submission, and may be highlighted within the pages of the journal.
All participants in the publication and peer review process—not only authors but also peer reviewers, editors, and Editorial Board members of the JABG—must consider their conflicts of interest when fulfilling their roles in the process of submission, article review, and publication, and must disclose all relationships that could be viewed as potential conflicts of interest.
All authors should disclose their conflicts of interest, i.e., (1) financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony), (2) personal relationships, (3) academic competition, and (4) intellectual passion.
Authors must include these conflicts of interest on the title page and certify the disclosure of any conflict of interest with their signatures. If the undisclosed conflict of interest is suspected in a submitted manuscript or published article, a committee composed of Editorial Board members will be held and discussed, and JABG will follow the process of the applicable COPE flowchart (https://publicationethics.org/guidance).
When conducting experiments on animals, authors should adhere to the local or national requirements for the care and use of laboratory animals. All animal experiments should be reviewed by the Institutional Animal Care and Use Committee (IACUC) of the organization at which the experiment was carried out. The manuscript must include the statement of IACUC compliance that should appear as the first item in the Methods section. If necessary, the editor or reviewers may request a copy of the document to resolve the questions about IACUC approval and its related issues. JABG retains the right to reject any manuscript on the basis of unethical or misconduct of animal studies. It is also recommended that the sex of animals and, if any, influence or association of sex on the results of the study should be described.
The authors should be responsible for the credibility of all allegations of scientific misconduct, e.g., suspected fabrication or falsification of data, double publication, or plagiarism. Submitted manuscripts must not have been previously published and not be under consideration for publication elsewhere. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the editorial board of JABG. Submitted manuscripts are screened for possible plagiarism or duplicate publication by Crossref Similarity Check upon receipt by the journal. If a redundant or duplicate publication is attempted or occurs without such notification, the submitted manuscript will be rejected immediately, and the incident will be announced in JABG, and their institutions may be informed. There will also be penalties imposed by the JABG ethics committee. It is the responsibility of the authors to request permission from the appropriate authority for any material that is being reproduced for the publication in JABG. This requirement applies to text, figures, tables, audio and/or video.
With any allegation raised by the reviewers, readers, or the third party, the editor-in-chief together with the JABG ethics committee will first attempt to address the matter with the corresponding author. In case this fails to resolve the situation satisfactorily, the editor-in-chief will contact the institution of the corresponding author to request an investigation; the editor-in-chief may also contact the coauthors and/or the funder(s) of the published research.
Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published, and 4) agreeing to be accountable for all aspects of the work in ensuring that the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The authors should meet these 4 conditions. If the number of authors is equal to or greater than 2, there should be a list of each author’s role in the submitted paper. The description of co-first authors is accepted if the corresponding author believes that such roles existed in contributing to the manuscript.
Correction of authorship: After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the corresponding author(s). This letter must be signed by all authors of the paper. JABG does not correct authorship after final acceptance unless a mistake has been made by the editorial staff.
The roles of all authors must be specified upon submission and documented in the manuscript.
Role of corresponding author: The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process. The corresponding author typically ensures that all of the journal’s administrative requirements, such as providing the details of authorship, ethics committee approval, clinical trial registration documentation, and conflicts of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely manner, and after publication should be available to respond to critiques of the work and cooperate with any requests from the journal for data or additional information or questions about the article.
Co-first authors: JABG allows multiple co-first authors (maximum two) for one article, provided that a notice of equal contribution is submitted and accepted by JABG, and that the study was clearly conducted jointly by the designated co-first authors.
Contributors: Any researcher who does not meet all 4 criteria for authorship discussed above but contributes substantively to the study in terms of idea development, manuscript writing, conducting research, data analysis, and/or financial support should have their contributions listed in the Acknowledgments section of the article.
All submitted manuscripts should be original and should not be in consideration by other scientific journals for publication. Any part of the accepted manuscript should not be duplicated in any other scientific journal without permission of the Editorial Board, although the figures and tables can be used freely if the original source is verified according to the Creative Commons Attribution License. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from other journals that are not open access.
It is possible to republish manuscripts if the manuscripts satisfy the condition of secondary publication of the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals” by International Committee of Medical Journal Editors (ICMJE), available from https://icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html.
These are:
JABG defines research and publication misconduct as follows. These definitions are based on the COPE and ICMJE guidelines:
When JABG encounters suspected cases of research or publication misconduct—including but not limited to redundant (duplicate) publication, plagiarism, data fabrication or falsification, inappropriate changes in authorship, undisclosed conflicts of interest, ethical concerns in submitted manuscripts, misappropriation of ideas or data by reviewers, or complaints against editors—these will be managed in accordance with the guidelines and flowcharts of the Committee on Publication Ethics (COPE): https://publicationethics.org/guidance.
Preliminary Review: Upon receiving a report or identifying a possible case of misconduct, the Editorial Board will conduct an initial review to assess whether the allegation has merit.
Formal Notification: If a formal investigation is warranted, the corresponding author (or the individual(s) involved) will be notified in writing, informed of the allegations, and given an opportunity to respond and provide a written explanation.
Review and Decision: The Editorial Board will review all evidence, including statements from all parties, in accordance with COPE principles. Decisions will be made by consensus or majority vote within the Board.
Confidentiality: The identity of the whistleblower (if any) and all parties involved will be kept confidential to the extent permitted by law and ethical guidelines. All communications will be handled with strict discretion.
Actions Taken: If misconduct is confirmed, the Editorial Board may take one or more of the following actions:
JABG is committed to preserving the integrity of the academic record. When necessary, the journal will publish errata, corrigenda, retractions, clarifications, or formal apologies in accordance with the outcome of the investigation.
The Editorial Board of Journal of Animal Breeding and Genomics (JABG) is committed to upholding the highest standards of publication ethics and scholarly integrity. To this end, the editors are responsible for:
In addition, all editors shall:
The Editorial Board is also committed to maintaining transparency, fairness, and confidentiality throughout the peer review and publication process.
This policy is based on international guidelines and best practices regarding the use of generative AI and AI-assisted tools in scholarly publishing.
Authors may use generative AI or AI-assisted tools solely to enhance the readability and language quality of their work. However, these tools must not be used to generate scientific content, such as data interpretation, hypothesis generation, conclusions, or recommendations. Generative AI must not replace essential scholarly tasks that require original intellectual contribution.
Use of these tools should be conducted with human oversight and control. Authors must critically review and edit any AI-generated content, recognizing that such tools may produce inaccurate, incomplete, or biased information.
Authors are fully responsible and accountable for the entire content of their submitted manuscript, regardless of the use of AI.
Authors must disclose any use of generative AI or AI-assisted tools in a dedicated section titled:
Declaration of Generative AI and AI-assisted Technologies in the Writing Process
This section should be placed before the References list in the manuscript file.
Example statement:
During the preparation of this work, the author(s) used [NAME of TOOL / SERVICE] to [REASON]. The author(s) reviewed and edited the content as needed and take full responsibility for the content of this publication.
This disclosure promotes transparency and complies with the terms of use of AI tools.
Generative AI tools must not be listed as authors or co-authors. Authorship entails accountability for the integrity of the work and the ability to approve the final version—duties that only humans can fulfill.
The use of generative AI or AI-assisted tools to create, modify, or manipulate images in the manuscript is strictly prohibited. This includes:
Acceptable adjustments:
Authors should ensure that all image modifications comply with JABG’s Research and Publication Ethics Policy.
Reviewers may use generative AI tools (e.g., ChatGPT, Gemini, Copilot, Claude) to assist in the peer review process. However, they must ensure that:
For inquiries regarding submission, peer review, acceptance certification, or copyright, please contact the editorial office via the journal website:
https://www.jabg.org
Jaemin Kim
Animal Genomics Lab., Gyeongsang National University, Republic of Korea
E-mail: jmkim85@gnu.ac.kr
DocuHut Co., Ltd.
Research Institute of Energy Resources 506, Seoul National University
Gwanak-ro 1, Gwanak-gu, Seoul, 08826, Republic of Korea
Tel: 82-2-2274-6771, Fax: 82-2-6902-0698, E-mail: project@docuhut.com